NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,170 filers reported holding NOVARTIS A G in Q4 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,187 | -3.0% | 266,901 | -4.0% | 0.10% | +3.1% |
| Q2 2023 | $28,042 | +11.7% | 277,896 | +1.8% | 0.10% | -4.9% |
| Q1 2023 | $25,113 | -9.3% | 272,968 | -10.6% | 0.10% | -4.6% |
| Q4 2022 | $27,698 | -99.9% | 305,309 | +1.9% | 0.11% | +10.2% |
| Q3 2022 | $22,776,000 | -8.5% | 299,636 | +1.6% | 0.10% | -12.5% |
| Q2 2022 | $24,885,000 | -3.1% | 294,796 | +0.8% | 0.11% | +1.8% |
| Q1 2022 | $25,672,000 | +19.5% | 292,561 | +19.1% | 0.11% | +32.5% |
| Q4 2021 | $21,484,000 | +6.3% | 245,615 | -0.6% | 0.08% | -3.5% |
| Q3 2021 | $20,218,000 | -6.8% | 247,214 | +3.9% | 0.09% | -10.4% |
| Q2 2021 | $21,699,000 | +10.0% | 237,825 | +3.1% | 0.10% | 0.0% |
| Q1 2021 | $19,718,000 | -10.1% | 230,675 | -0.7% | 0.10% | -9.4% |
| Q4 2020 | $21,926,000 | +4.8% | 232,194 | -3.5% | 0.11% | -10.9% |
| Q3 2020 | $20,925,000 | -2.4% | 240,627 | -2.0% | 0.12% | -11.9% |
| Q2 2020 | $21,437,000 | +2.0% | 245,439 | -3.7% | 0.14% | -18.7% |
| Q1 2020 | $21,009,000 | -13.8% | 254,804 | -1.0% | 0.17% | +3.8% |
| Q4 2019 | $24,369,000 | +13.0% | 257,354 | +3.7% | 0.16% | +1.9% |
| Q3 2019 | $21,573,000 | -2.7% | 248,251 | +2.2% | 0.16% | -7.6% |
| Q2 2019 | $22,173,000 | +0.4% | 242,828 | +5.7% | 0.17% | -6.6% |
| Q1 2019 | $22,087,000 | +19.3% | 229,740 | +6.5% | 0.18% | +2.2% |
| Q4 2018 | $18,513,000 | +2.2% | 215,746 | +2.7% | 0.18% | +14.1% |
| Q3 2018 | $18,106,000 | +29.2% | 210,141 | +13.3% | 0.16% | +15.6% |
| Q2 2018 | $14,015,000 | -7.2% | 185,530 | -0.6% | 0.14% | -11.2% |
| Q1 2018 | $15,096,000 | +1.6% | 186,710 | +5.5% | 0.15% | -1.3% |
| Q4 2017 | $14,857,000 | +5.2% | 176,953 | +7.5% | 0.15% | -4.3% |
| Q3 2017 | $14,127,000 | +8.6% | 164,549 | +5.6% | 0.16% | -0.6% |
| Q2 2017 | $13,007,000 | +10.8% | 155,829 | -1.4% | 0.16% | +3.8% |
| Q1 2017 | $11,737,000 | +23.8% | 158,029 | +21.4% | 0.16% | +9.1% |
| Q4 2016 | $9,478,000 | +74.8% | 130,119 | +89.5% | 0.14% | +49.0% |
| Q3 2016 | $5,423,000 | +30.0% | 68,682 | +19.2% | 0.10% | -11.9% |
| Q1 2016 | $4,173,000 | -33.6% | 57,603 | -21.1% | 0.11% | -32.7% |
| Q4 2015 | $6,280,000 | -15.0% | 72,993 | -9.1% | 0.16% | -22.1% |
| Q3 2015 | $7,384,000 | -99.9% | 80,335 | +8.4% | 0.21% | +35.9% |
| Q2 2015 | $7,288,955,000 | +106044.7% | 74,120 | +6.4% | 0.15% | +19.5% |
| Q1 2015 | $6,867,000 | -99.9% | 69,634 | +6.8% | 0.13% | +5.8% |
| Q4 2014 | $6,039,601,000 | +4.7% | 65,180 | +6.4% | 0.12% | +0.8% |
| Q3 2014 | $5,768,591,000 | +17.4% | 61,283 | +12.9% | 0.12% | +12.1% |
| Q2 2014 | $4,912,070,000 | +37.5% | 54,259 | +29.2% | 0.11% | +24.4% |
| Q1 2014 | $3,571,882,000 | +10.0% | 42,012 | +4.0% | 0.09% | 0.0% |
| Q4 2013 | $3,246,564,000 | -7.7% | 40,390 | -11.9% | 0.09% | -18.9% |
| Q3 2013 | $3,517,622,000 | +534.4% | 45,856 | +484.7% | 0.11% | +82.8% |
| Q2 2013 | $554,503,000 | – | 7,842 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |